Skip to content

Simon Read, Director at Dianthus Therapeutics, sold DNTH on Aug 10, 2026

Data as of Oct 16

▼ SELL$44.4K397 shares at $111.77Simon Read DirectorDNTH Dianthus Therapeutics, Inc.
Watch DNTH
Traded
Aug 10, 2026
Disclosed
Aug 11, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Simon Read, Director at Dianthus Therapeutics, sold DNTH on Aug 10, 2026TRADEDDISCLOSED
DNTHSimilar stocks (XLV — its sector index fund), rebased to DNTH's price on the disclosure day
DNTH since disclosure
−33.6%
after the sale
Similar stocks (XLV) since disclosure
+5.2%
XLV — its sector index fund

Change in closing price from Aug 11, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLSimon Read DirectorDNTH Dianthus Therapeutics, Inc.$7.5Kdisclosed Aug 11 · filed 1 day after the trade
  2. ▼ SELLSimon Read DirectorDNTH Dianthus Therapeutics, Inc.$90.5Kdisclosed Aug 11 · filed 1 day after the trade
  3. ▼ SELLSimon Read DirectorDNTH Dianthus Therapeutics, Inc.$79.7Kdisclosed Aug 11 · filed 1 day after the trade
  4. ▼ SELLSimon Read DirectorDNTH Dianthus Therapeutics, Inc.$29.9Kdisclosed Aug 11 · filed 1 day after the trade
  5. ▼ SELLSimon Read DirectorDNTH Dianthus Therapeutics, Inc.$52.2Kdisclosed Aug 11 · filed 1 day after the trade

See every trade on DNTH →